https://ansm.sante.fr/tableau-acces-derogatoire/nirogacestat 2025 false false false France French administration, oral nirogacestat ogsiveo summary of product characteristics package leaflet guidelines for drug use Desmoid Tumors Refractory Desmoid Fibromatosis nirogacestat